INGALLS & SNYDER LLC 13D/13G Filings for Concert Pharmaceuticals, Inc. (CNCE)

INGALLS & SNYDER LLC 13D and 13G filings for Concert Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-09
4:41 pm
Sale
2005-12-3113GConcert Pharmaceuticals, Inc.
CNCE
INGALLS & SNYDER LLC1,396,003
4.550%
-68,709decrease
(-4.69%)
Filing
2020-01-23
2:21 pm
Purchase
2005-12-3113GConcert Pharmaceuticals, Inc.
CNCE
INGALLS & SNYDER LLC1,464,712
6.100%
264,937increase
(+22.08%)
Filing